ARCHIVES

In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts”

This article is from The Cancer Letter archive.

Vol. 02 No. 13 | March 26, 1976

Download PDF Visit The Full Archive

Related Articles

Regular NSAIDs Use Protects Smokers From Lung Cancer

March 28, 2003

NCCS Networker Volume 9 Issue 3, Summer 1995

June 12, 1995

CCOPs Get $1 Million More, Payline Raised To 228 Plus Exceptions

May 29, 1987

NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement

June 26, 1987

Panel Recommends Peer Review “Fine Tuning” Changes Including Mandatory Service By All NIH Grantees

January 6, 1984

CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs.

March 16, 2007